ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1390

Distinct Patterns of Multimorbidity Are Associated with Longitudinal Disease Activity and Functional Status in a Multicenter, Prospective Rheumatoid Arthritis Cohort

Sarah Dutt1, Punyasha Roul2, Yangyuna Yang3, Kaleb Michaud3, Brian Sauer4, Grant Cannon5, Joshua Baker6, Jeffrey Curtis7, Ted Mikuls8 and Bryant England3, 1University of Nebraska Medical Center, Omaha, 2UNMC, Omaha, NE, 3University of Nebraska Medical Center, Omaha, NE, 4Salt Lake City VA/University of Utah, Salt Lake City, UT, 5Salt Lake City VA, Salt Lake city, 6University of Pennsylvania and Corporal Michael J. Crescenz VA Medical Center, Philadelphia, 7Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 8Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

Meeting: ACR Convergence 2022

Keywords: Comorbidity, Disease Activity, functional status, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: RA – Diagnosis, Manifestations, and Outcomes Poster III

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Rheumatoid arthritis (RA) predisposes to the development of other chronic conditions such as osteoporosis, cardiovascular disease, and lung disease. Previously, we used unsupervised machine learning and real-world data to derive novel patterns of multimorbidity that were overrepresented in patients with RA and included mental health and substance abuse, cardiovascular, metabolic, and chronic pain multimorbidity. The prognostic value of these multimorbidity patterns for RA-related outcomes is unknown.

Methods: We performed a cohort study using the Veterans Affairs Rheumatoid Arthritis (VARA) Registry, a multicenter, prospective RA cohort. The presence of forty-four chronic conditions was assessed through diagnostic codes from outpatient and inpatient encounters using linked administrative data. Patients were then assigned the previously identified multimorbidity patterns based on these conditions prior to enrollment. Additionally, we assessed the number of unique multimorbidity patterns present in each patient. RA disease activity (28-joint Disease Activity Score [DAS28]) and functional status (multidimensional Health Assessment Questionnaire [MDHAQ]) were collected longitudinally per routine care and averaged over each year of follow-up. Associations of these patterns with DAS28, MDHAQ, and individual RA disease activity measure components over up to 5-years of follow-up was determined using generalized estimating equations (GEE) adjusting for relevant covariates such as demographics, smoking status, RA autoantibodies, and medications. Interaction terms tested between multimorbidity patterns and follow-up duration were not significant (all p >0.20).

Results: Results: We studied 2,941 RA patients, of which the majority were male (88.4%), had a smoking history (79.3%), and RF or anti-CCP seropositive (85.8%). The metabolic multimorbidity pattern was most frequent (64.2%), followed by chronic pain (48.6%), mental health and substance abuse (23.2%), and cardiovascular multimorbidity (12.4%). Patients with mental health and substance abuse, cardiovascular, and chronic pain patterns of multimorbidity had higher DAS28 and MDHAQ values throughout follow-up (Figure 1). Similar findings were observed with the Clinical Disease Activity Index (Table 1). Metabolic multimorbidity was not associated with DAS28 or MDHAQ. A greater number of multimorbidity patterns was associated with higher DAS28 and MDHAQ scores (p trend < 0.001 for both, Figure 2). Mental health and substance abuse as well as chronic pain multimorbidity tended to be associated with patient and provider global scores and tender joint count (Table 1). The cardiovascular pattern of multimorbidity was associated with provider global scores, tender and swollen joint count, and acute phase reactants.

Conclusion: The presence of mental health and substance abuse, chronic pain, and cardiovascular patterns of multimorbidity was associated with higher RA disease activity and poorer functional status in RA. Identifying and addressing these different patterns of multimorbidity as part of holistic care may facilitate achievement of RA treatment targets and improve long-term patient outcomes.

Supporting image 1

Figure 1: Associations of multimorbidity patterns with RA disease activity and functional status over up to five years of follow-up

Supporting image 2

Figure 2: Associations of the number of multimorbidity patterns with RA disease activity and functional status over up to five years of follow-up

Supporting image 3

Table 1: Associations of multimorbidity patterns with Clinical Disease Activity Index (CDAI) score and individual component measures of disease activity.


Disclosures: S. Dutt, None; P. Roul, None; Y. Yang, None; K. Michaud, None; B. Sauer, None; G. Cannon, None; J. Baker, Bristol Myers Squibb, Pfizer, CorEvitas LLC, Burns-White, LLC, RediTrex; J. Curtis, Amgen, Bristol-Myers Squibb (BMS), CorEvitas, IlluminationHealth, Janssen, Lilly, Myriad, Novartis, Pfizer, Sanofi, UCB, Aqtual, Bendcare, FASTER, GlaxoSmithKlein (GSK), Labcorp, Scipher, Setpoint, United Rheumatology, AbbVie, ArthritisPower; T. Mikuls, Gilead Sciences, Bristol-Myers Squibb, Horizon, Sanofi, Pfizer Inc; B. England, Boehringer-Ingelheim.

To cite this abstract in AMA style:

Dutt S, Roul P, Yang Y, Michaud K, Sauer B, Cannon G, Baker J, Curtis J, Mikuls T, England B. Distinct Patterns of Multimorbidity Are Associated with Longitudinal Disease Activity and Functional Status in a Multicenter, Prospective Rheumatoid Arthritis Cohort [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/distinct-patterns-of-multimorbidity-are-associated-with-longitudinal-disease-activity-and-functional-status-in-a-multicenter-prospective-rheumatoid-arthritis-cohort/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/distinct-patterns-of-multimorbidity-are-associated-with-longitudinal-disease-activity-and-functional-status-in-a-multicenter-prospective-rheumatoid-arthritis-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology